VANCOUVER, BC, Sept. 7, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF) (“Filament” or the “Company”), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on the OTC Pink Market (the “OTC”) in the United States under the symbol…


Previous articlePT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and the Repurposing of Current Drugs
Next articleGlutamate’s Role in Rapidly-Acting Antidepressants